Treatment of cardiac arrhythmias.
D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy*; D001281:Atrial Fibrillation / Q000628:therapy; D001282:Atrial Flutter / Q000628:therapy; D004070:Digitalis / Q000009:adverse effects / Q000627:therapeutic use; D004077:Digoxin / Q000627:therapeutic use; D004554:Electric Countershock; D006327:Heart Block / Q000188:drug therapy; D006352:Heart Ventricles; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy; D010138:Pacemaker, Artificial; D010672:Phenytoin / Q000627:therapeutic use; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013610:Tachycardia / Q000628:therapy; D013614:Tachycardia, Paroxysmal / Q000628:therapy; D014693:Ventricular Fibrillation / Q000628:therapy
D010672:Phenytoin; D004077:Digoxin; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide